INTRODUCTION
Basic fibroblast growth factor-2 (bFGF-2) is a heparinbinding growth factor that exhibits potent angiogenic activity and mitogenic ability in mesenchymal cells [1] [2] [3] [4] [5] [6] [7] and periodontal ligament cells [8] [9] [10] [11] . Several studies have reported that bFGF-2 induces potent periodontal tissue regeneration along with new alveolar bone and cementum formation without aberrant healing such as root resorption and ankylosis in critical size defects of animal models [12] [13] [14] . Some studies reported that the combination of bFGF-2 and granular betatricalcium phosphate (β-TCP) implanted in 1-wall and 2-wall periodontal defects resulted in good periodontal regeneration in dogs 15, 16) . β-TCP, which belongs to the group of bioactive bioceramics of completely synthetic origin, is well known as a biodegradable material with good osteoconductive capacity and clinical efficacy [17] [18] [19] [20] . Recently, we demonstrated that tunnel structured β-TCP induced an increase in cells and blood vessels derived from the residual bone when compared with β-TCP composed of macropores with small connecting area, which enhanced periodontal regeneration in class III furcation defects 21) . We hypothesized that the combination of bFGF-2 and tunnel-pipe β-TCP may have added effects on periodontal regeneration.
Adequate regeneration is difficult to achieve in cases of class III furcation defects and horizontal bone defects. To date, no studies have evaluated the effect of the combination of bFGF-2 and β-TCP implanted in refractory periodontal lesions such as class III furcation defects. The purpose of this study was to evaluate periodontal regeneration histopathologically following implantation of bFGF-2 in conjunction with β-TCP in surgically created class III furcation defects in dogs.
MATERIALS AND METHODS

Animals
Thirty mandibular premolar teeth of five beagle dogs (female, 1 year old; mean weight, 9.5 kg) were used. This study was performed in accordance with the guidelines for care and use of laboratory animals of the Hokkaido University Graduate School of Medicine. The dogs were subjected to plaque control measures consisting of twiceweekly brushing and application of 0.5% chlorhexidine gluconate solution in order to establish healthy gingival conditions prior to surgical procedures. 
Preparation of tunnel-pipe β-TCP and the combination of bFGF-2 and β-TCP
The β-TCP slurry was obtained by kneading tricalcium phosphate (Ca 3(PO4)2) with polyvinyl alcohol and distilled water at a molar ratio of 8:2:10. Many hollow cylindrical particles with an inner diameter of 300 µm, outer diameter of 500 µm and length of 1-2 mm were prepared by extrusion molding of the slurry. The particles were collected and pressed to release water. The particles of tunnel-pipe β-TCP were arranged irregularly, forming a cube with sides of 5 mm (Figs. 1a and 1b) . Final β-TCP in which the tunnel pipe structure was gathered and fixed was sintered at a maximum temperature of 1,180 degree C (°C) for 3 h in air. The porosity of tunnel-pipe β-TCP was 72%, which included open porosity and closed porosity, calculated as follows: porosity (%)=(1−bulk density of the sample/true density)×100, *bulk density of the sample=W/V, *true density=3.07/cm 3 (β-TCP). Data on the images obtained by X-ray powder diffraction (XRD) of tunnel-pipe β-TCP were provided by the manufacturer. All diffraction peaks were assigned to single-phase β-TCP and no other phases were observed. The average crystal size was 175 nm. The compressive strength was 0.8 MPa. The solution containing 0.3% bFGF-2 (37.5 mg) was then loaded into β-TCP (bFGF-2/β-TCP). bFGF-2/β-TCP was lyophilized and stored at −80 °C until implantation.
Surgery and implantation
The surgical procedures were performed under anesthesia by intramuscular injection of medetomidine hydrochloride (5 µg/kg, Domitor Japan) and ketamine hydrochloride (2.9 mg/kg, Ketaral 50 ® , Sankyo, Tokyo, Japan) and local infiltration (2% with 1:80,000 epinephrine, Xylocaine ® , DENTSPLY SANKIN, Tokyo, Japan). After reflection of a mucoperiosteal flap, the interradicular bone of all second, third and fourth premolars was completely removed with rotating burs under irrigation and hand micro Ochsenbein chisels to create through-and-through furcation defects. The defect height from the cemento-enamel junction (CEJ) to the reduced alveolar crest was 4 mm. The exposed root surfaces were planed with curettes in order to remove the periodontal ligament and cementum (Fig. 1c) . At this point, the teeth were randomly assigned to one of three treatment groups based on a random computergenerated list.
In the TF group (n=10), bFGF-2/β-TCP was shaped using a diamond bur to fit the furcation space. Then, bFGF-2/β-TCP was implanted into the furcation (Fig.  1d ). In the F group (n=10), the root-planed surface was conditioned with 24% ethylenediamine tetraacetic acid (EDTA) (pH 7.4) for 3 min and rinsed with PBS. Then, bFGF-2 solution was applied to the root surface in the furcation defect. The furcation was not treated in the remaining 10 teeth, which served as control (control group) (n=10).
After implantation, the flaps were positioned with the gingival margins of the flaps at the CEJ and sutured.
Wound management
Sutures were removed 10 days after the surgical procedure. Plaque control measures included weekly brushing and application of 0.5% chlorhexidine gluconate solution throughout the healing period (Fig. 1e) .
Histological processing and histometric analysis
The dogs were sacrificed 8 weeks after the surgical procedure. Tissue blocks including teeth, bone and soft tissues were resected. Blocks were fixed in 10% buffered formalin, decalcified in 10% EDTA solution, trimmed, dehydrated, and embedded in paraffin. Serial sections of thickness 4 µm were prepared in the mesio-distal plane. Sections were then prepared from the area in the middle of the buccal section containing the line connecting the buccal surfaces of the mesial and distal roots and the lingual section containing the line connecting the lingual surfaces of the mesial and distal roots. Three bucco-lingual sections (52 µm apart) were stained with hematoxylin and eosin and the nearby sections were stained with tartrate-resistant acid phosphatase (TRAP) stain.
Measurements of each specimen were carefully performed by one examiner (YH) who was blinded to the study protocol. The following measurements were performed using Scion Image ® (National Institute of Health) (Fig. 1f) . Prestudy calibration exercises revealed that the intra-examiner calibration error was <5% for all parameters measured. The area from the apical border of the mesial and distal roots to the fornix was regarded as the bone defect area. The tissues formed from the apical border in a coronal direction after each treatment were regarded as the newly formed tissue. The following parameters were also determined: 1) Epithelium (%): linear extension of root surface covered by epithelial tissue (E)/length of the root surface from the mesial notch to the distal notch (RL)×100. 2) New cementum (%): total length of regenerated cementum (NC)/RL×100. 3) New bone area (%): regenerated bone area and β-TCP area surrounded with bone tissue (NB)/ Bone defect area (BDA)×100. 4) Root resorption (%): total length of root resorption (RR)/RL×100. 5) Ankylosis (%): total length of ankylosis (A)/ RL×100. 6) β-TCP area (%): β-TCP area in the TF group (β-TCP)/BDA×100.
Data analysis
The mean±SD of each measurement was calculated for each tooth from selected sections. Statistical differences were analyzed using the Kruskal-Wallis test. All statistical procedures were performed using SPSS 10.0 J (S.P.S.S. Co. Ltd., Tokyo, Japan).
RESULTS
Clinical observations
Healing progressed uneventfully in all cases following surgery. Clinically, there were minimum indications of postoperative inflammation in the gingiva during the healing phase.
Histologic observations
In the TF group (Figs. 2a, 2d and 2e), downgrowth of gingival epithelium was not observed in the furcation of 9/10 specimens. Extensive new bone formation was observed up to the fornix of the furcation (Fig. 2a) . Small amounts of β-TCP remained within the defects. On the resorbed inner and outer surfaces of β-TCP, new bone had formed. Furthermore, blood vessels and new bone had formed in the center of each pipe tunnel directed horizontally (Fig. 2d) . Numerous multinucleated cells were seen adhered to the β-TCP surface and there was new bone in the entire furcation (Figs. 3a-3d) . New cementum had formed on the root-planed surface near the top of the furcation space. New connective tissue fibers oriented parallel or inclined to the root surface and embedded in both new cementum and new bone were observed (Fig. 2e ).
In the F group (Figs. 2b, 2f and 2g) , gingival epithelium was observed in the fornix of the furcation in all specimens. New bone had formed in two-thirds of the furcation defect (Fig. 2b) . New bone formation was observed along the mesial space onto the distal rootsurface and the distal space onto the mesial root-surface with a dimple in the center. Many osteoclasts were observed on the bone surface of the coronal new bone and bone marrow (Figs. 3e-3i ). New cementum with inserting collagen fibers had formed on the root-planed surface (Fig. 2g) . New connective tissue fibers oriented parallel or inclined to the root surface were observed. In the C group (Figs. 3c, 3h and 3i) , gingival epithelium was observed in the fornix of the furcation in all specimens and inflammatory cells appeared in the connective tissue under the epithelium (Fig. 3h ). Limited new bone had formed at the bottom of the furcation defect near the residual bone. Limited amounts of new cementum with inserting collagen fibers had formed on the bottom half of the root-planed surface (Fig. 3i) .
Histometric analysis
New bone area was 75.8±6.3% in the TF group, significantly greater than that in the F group (p<0.05) and C group (p<0.01) ( Table 1) . New cementum was significantly greater in the TF group and F group compared to the C group (p<0.01), and there were no significant differences between the TF group and the F group (Table 1) . The epithelium was significantly less in the TF group compared to the F group (p<0.05) and C group (p<0.01) ( Table 1) . The remaining β-TCP was 22.4±6.3% in the TF group.
DISCUSSION
Class III furcation involvements are considered to be the most difficult of all periodontal lesions to achieve regeneration [22] [23] [24] . One of the reasons is that the cells from residual bone and periodontal ligament may not be able to populate into the furcation without interference by the gingival epithelium, particularly in furcations with a large entrance and wide and deep defects [22] [23] [24] . bFGF-2 has the potential to increase vascularization and the population of fibroblastic cells and osteoblasts in vitro and vivo. In intrabony and class II furcation defects in preclinical models, it has been reported that bFGF-2 effectively induced periodontal tissue regeneration [12] [13] [14] . However, the capability of bFGF-2 to regenerate periodontal tissue in class III furcation defects has not been studied. Therefore, the present study evaluated the regenerative potential of bFGF-2 applied using two methods in class III mandibular furcation defects in dogs.
Previous studies revealed that an optimal dose of bFGF-2 showed potential for periodontal regeneration in rats 25) . We attempted to determine the optimal dose of bFGF-2 for periodontal regeneration in dogs from several previous reports. bFGF-2 had a dose-dependent effect on periodontal regeneration at a dose ranging from 0 to 0.16% per implant [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [26] [27] [28] [29] . Hayashi et al. reported that new bone formation was smaller in the 0.56% bFGF-2 (100 µg bFGF-2/3×3×2 mm gelatin hydrogel) implant compared to the 0.056% bFGF-2 (10 µg bFGF-2/3×3×2 mm gelatin hydrogel) implant; however, there were no significant differences between them 29) . Takayama et al. observed that new bone formation was greater in a 0.4% bFGF-2 implant compared to a 0.01% bFGF-2 implant; however, new cementum formation was smaller in the 0.4% bFGF-2 implant compared to the 0.01%b FGF-2 implant 13) . From these studies, we speculated that the optimal dose for periodontal regeneration would be within 0.16% to 0.4% bFGF-2. Therefore, a solution containing 0.3% bFGF-2 was loaded into β-TCP (bFGF-2/β-TCP) in this study.
In the TF group, we observed that β-TCP remained and new bone formed within and around β-TCP up to the fornix of the furcation defect. New bone without β-TCP was 53.5% in the TF group in this study, greater than that (38.6%) in the previous study which evaluated tunnel-pipe β-TCP implantation 21) . The precise binding mechanisms of bFGF-2 to β-TCP surface and the preservation and release of bFGF-2 from β-TCP are not known. Our results confirm that tunnel-pipe β-TCP could serve as a carrier of bFGF-2. When β-TCP is used as a carrier of bFGF-2, β-TCP may entrap bFGF-2 and thus inhibit the diffusion of bFGF-2 out of furcation defects. As a result, high concentrations of bFGF-2 would be available for periodontal repair in a wide area of the defect. Other mechanisms may explain these results. β-TCP, which functions as a scaffold, has prominent osteoconductive properties and new bone formation directed on β-TCP seemed to increase the volume of new bone complex. Furthermore, the tunnel structure of β-TCP can act as a scaffold for vascularization 21) . New blood vessels and new bone formation in the center of the pore structure were observed in the TF group. Vascularization would ensure an adequate supply of nutrients, osteoprogenitor cells and growth factors that support the formation of osseous tissue.
On the other hand, the regenerated bone area in the F group was significantly smaller than that in the TF group in this study. New bone formation in the F group was observed along the mesial space onto the distal rootsurface and the distal space onto the mesial root-surface and the new bone had a dimple in the center. It has been reported that the concentration of bFGF-2 regulates the cell proliferation of osteoblasts in vitro 3, 30, 31) . The present results suggested that bFGF-2 applied on the decalcified dentin surface may promote proliferation and differentiation of osteoblasts near the root surface. Cells in the middle portion between the mesial and distal roots are less affected by bFGF-2 and cannot form new bone. Downgrowth of junctional epithelium was significantly smaller in the TF group compared to the F and control groups. The different application methods of bFGF-2 may explain the different types of epithelial repair in this study. These results are similar to the findings in one-wall defects and two-wall defects in dogs following application of the combination of bFGF-2 and β-TCP 15, 16) . However, the effect of bFGF-2 on gingival epithelial cells in vivo remains unclear. Murakami et al. observed that downgrowth of junctional epithelium was limited by bFGF-2 application when compared with sham operation in class II furcation defects 14) . In general, bFGF-2 has been reported to induce the proliferation of not only periodontal ligament cells but also gingival epithelial cells in a dose-dependent manner in vitro 8, 32) . However, Takayama et al. reported that co-stimulation with fetal calf serum inhibited bFGF2-induced-proliferation of gingival epithelial cells, but synergistically enhanced bFGF-2-induced periodontal ligament cell proliferation 32) . It was suggested that the biological effects on periodontal ligament cells would be synergistically increased in vivo and that bFGF-2 acts differently on periodontal ligament cells and gingival epithelial cells in terms of the proliferative response. In the F group, because new bone formation appeared like a dimple, the potency of bFGF-2 in the center might be smaller than that in the space near the root-surface and interference by the gingival epithelium might increase towards the fornix. Also, downgrowth of junctional epithelium in the F group was not statistically different from that in the C group in this study.
New cementum formation in the TF group was not significantly different from that in the F group, but was significantly greater than that in the control group. This is in accordance with the findings of Oi et al. (new cementum formation, 70%) and Anzai et al.
(new cementum formation, 80%), who reported similar observations in one-wall defects and two-wall defects in dogs following application of bFGF-2 in conjunction with β-TCP 15, 16) . The findings of the present experiment demonstrated that the combination of bFGF-2 and β-TCP failed to interfere with new cementum formation by bFGF-2.
The resorption of β-TCP in vivo involves chemical dissolution 33, 34) and phagocytosis by osteoclasts 15, 17) . β-TCP remained in 22.4±6.3% of the furcation area in the TF group. We had reported that β-TCP had been remained 34.2% in the furcation area following tunnelpipe β-TCP was implanted in similar class III furcation defects in dogs 21) . bFGF-2 might promote the resorption of β-TCP. Some previous studies using β-TCP have reported the appearance of osteoclasts. This finding may conflict with previous evidence which demonstrated that bFGF-2 regulated osteoclast differentiation 35) . The osteoclasts on the surface of β-TCP in the TF group might have promoted the resorption of residual β-TCP in the furcation defect. The osteoblasts noted beside the osteoclasts might actively form new bone by bone turnover in the future.
The β-TCP used in this study possessed a tunnelpipe structure with a pore size of 300 µm. We had previously reported that this material facilitated invasion of cells and blood from the surrounding tissues after implantation of the β-TCP, thus promoting vascular invasion and cell population at early stages of healing 21) . The growth factor bFGF-2 in the scaffold could then be applied with cells which are important for regeneration and periodontal regeneration could be enhanced. These results suggest that the periodontal regeneration induced by bFGF-2 could be enhanced aggressively by a combination of tunnel type β-TCP and that implantation of bFGF-2 in combination with β-TCP could be applied in complex periodontal bone defects. Further studies with long-term observations are required to clarify the effects of this combination in class III furcation defects.
CONCLUSION
bFGF-2 alone enhances connective tissue attachment in a manner similar to the combination of bFGF-2 and β-TCP. Furthermore, this combination enhances bone formation up to the fornix and inhibits epithelial downgrowth in class III mandibular furcation defects.
